Gallbladder Cancer
| Name | Price | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Carcinoembryonic Antigen-Related Cell Adhesion Molecule 3 Human Recombinant, Sf9 | Login | Carcinoembryonic Antigen-Related Cell Adhesion Molecule 3 Human Recombinant, Sf9 | ||||||||||||||||
|
||||||||||||||||||
| Carcinoembryonic Antigen Human Recombinant | Login | Carcinoembryonic Antigen Human Recombinant | ||||||||||||||||
|
||||||||||||||||||
| Carcinoembryonic Antigen-Related Cell Adhesion Molecule 7 Human Recombinant | Login | Carcinoembryonic Antigen-Related Cell Adhesion Molecule 7 Human Recombinant | ||||||||||||||||
|
||||||||||||||||||
| Carcinoembryonic Antigen-Related Cell Adhesion Molecule 21 Human Recombinant | Login | Carcinoembryonic Antigen-Related Cell Adhesion Molecule 21 Human Recombinant | ||||||||||||||||
|
||||||||||||||||||
| Carcinoembryonic Antigen-Related Cell Adhesion Molecule 3 Human Recombinant | Login | Carcinoembryonic Antigen-Related Cell Adhesion Molecule 3 Human Recombinant | ||||||||||||||||
|
||||||||||||||||||
| Carcinoembryonic Antigen-Related Cell Adhesion Molecule 6 Recombinant Human | Login | Carcinoembryonic Antigen-Related Cell Adhesion Molecule 6 Recombinant Human | ||||||||||||||||
|
||||||||||||||||||
| Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 Human Recombinant | Login | Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 Human Recombinant | ||||||||||||||||
|
||||||||||||||||||
| Carcinoembryonic Antigen Human Recombinant, His Tag | Login | Carcinoembryonic Antigen Human Recombinant, His Tag | ||||||||||||||||
|
||||||||||||||||||
| Carcinoembryonic Antigen-Related Cell Adhesion Molecule 3 Human Recombinant, Sf9 | Login | Carcinoembryonic Antigen-Related Cell Adhesion Molecule 3 Human Recombinant, Sf9 | ||||||||||||||||
|
||||||||||||||||||
| Carcinoembryonic Antigen Human Recombinant | Login | Carcinoembryonic Antigen Human Recombinant | ||||||||||||||||
|
||||||||||||||||||
| Anti-CEACAM-5/CD66e Antibody, Rabbit Polyclonal | Login | Anti-CEACAM-5/CD66e Antibody, Rabbit Polyclonal | ||||||||||||||||
|
||||||||||||||||||
| Anti-CEACAM-5/CD66e Antibody, Rabbit Polyclonal | Login | Anti-CEACAM-5/CD66e Antibody, Rabbit Polyclonal | ||||||||||||||||
|
||||||||||||||||||
| Anti-CEACAM-5/CD66e Antibody, Mouse Monoclonal | Login | Anti-CEACAM-5/CD66e Antibody, Mouse Monoclonal | ||||||||||||||||
|
||||||||||||||||||
| Anti-CEACAM-5/CD66e Antibody, Mouse Monoclonal | Login | Anti-CEACAM-5/CD66e Antibody, Mouse Monoclonal | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Anti-CEACAM-5/CD66e Antibody, Rabbit Monoclonal | Login | Recombinant Anti-CEACAM-5/CD66e Antibody, Rabbit Monoclonal | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Anti-CEACAM-5/CD66e Antibody, Rabbit Monoclonal | Login | Recombinant Anti-CEACAM-5/CD66e Antibody, Rabbit Monoclonal | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Anti-CEACAM-5/CD66e Antibody, Rabbit Monoclonal | Login | Recombinant Anti-CEACAM-5/CD66e Antibody, Rabbit Monoclonal | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Anti-CEACAM-5/CD66e Antibody, Rabbit Monoclonal | Login | Recombinant Anti-CEACAM-5/CD66e Antibody, Rabbit Monoclonal | ||||||||||||||||
|
||||||||||||||||||
| CEACAM5 / CD66e Antibody, Rabbit MAb | Login | CEACAM5 / CD66e Antibody, Rabbit MAb | ||||||||||||||||
|
||||||||||||||||||
| Anti-CEACAM-5/CD66e Antibody, Mouse Monoclonal | Login | Anti-CEACAM-5/CD66e Antibody, Mouse Monoclonal | ||||||||||||||||
|
||||||||||||||||||
| Anti-CEACAM-5/CD66e Antibody, Mouse Monoclonal | Login | Anti-CEACAM-5/CD66e Antibody, Mouse Monoclonal | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Labetuzumab | Login | Research Grade Labetuzumab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Altumomab | Login | Research Grade Altumomab | ||||||||||||||||
|
||||||||||||||||||
| Research Grade Tusamitamab | Login | Research Grade Tusamitamab | ||||||||||||||||
|
||||||||||||||||||
| CD66e Polyclonal Antibody | Login | CD66e Polyclonal Antibody | ||||||||||||||||
|
||||||||||||||||||


